TTM
$3.64B
YoY change
-1.2%
5Y CAGR
-1.7%
Peak year (2022)
$11.84B
Cumulative net income
$95.46B
Net Income history chart for AbbVie (ABBV) from 2009 to 2025
Latest: $4.23B
Net Income growth chart for AbbVie (ABBV) from 2009 to 2025
Latest: -1.2%
Net Income history table for AbbVie (ABBV) from 2009 to 2025
| 2025 | $4.23B | -1.2% | −$52.00M | ||
| 2024 | $4.28B | -12.0% | −$585.00M | ||
| 2023 | $4.86B | -58.9% | −$6.97B | ||
| 2022 | $11.84B | +2.5% | +$294.00M | ||
| 2021 | $11.54B | +150.0% | +$6.93B | ||
| 2020 | $4.62B | -41.4% | −$3.27B | ||
| 2019 | $7.88B | +38.6% | +$2.19B | ||
| 2018 | $5.69B | +7.1% | +$378.00M | ||
| 2017 | $5.31B | -10.8% | −$644.00M | ||
| 2016 | $5.95B | +15.7% | +$809.00M | ||
| 2015 | $5.14B | +190.0% | +$3.37B | ||
| 2014 | $1.77B | -57.0% | −$2.35B | ||
| 2013 | $4.13B | -21.7% | −$1.15B | ||
| 2012 | $5.28B | +53.7% | +$1.84B | ||
| 2011 | $3.43B | -17.8% | −$745.00M | ||
| 2010 | $4.18B | -9.9% | −$458.51M | ||
| 2009 | $4.64B | — | — |
- 2025$4.23B-1.2%
- 2024$4.28B-12.0%
- 2023$4.86B-58.9%
- 2022$11.84B+2.5%
- 2021$11.54B+150.0%
- 2020$4.62B-41.4%
- 2019$7.88B+38.6%
- 2018$5.69B+7.1%
- 2017$5.31B-10.8%
- 2016$5.95B+15.7%
- 2015$5.14B+190.0%
- 2014$1.77B-57.0%
- 2013$4.13B-21.7%
- 2012$5.28B+53.7%
- 2011$3.43B-17.8%
- 2010$4.18B-9.9%
- 2009$4.64B—
Net Income values are taken from AbbVie's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's current net income (TTM) is $3.64B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AbbVie (ABBV) most recent annual net income stands at $4.23B (2025) – edged down 1.2% year-over-year.
Through 2020–2025 (5 years), AbbVie net income delivered a -1.7% annualised rate; with a net decline across the window.
AbbVie net income peaked at $11.84B in 2022; the latest annual figure is $4.23B in 2025 (64.3% below peak).
$11.84B stands as the all-time-high annual net income, posted in 2022, against a low of $1.77B during 2014.
AbbVie Net Income by Year
AbbVie Net Income 2025: $4.23B
2025's net income for AbbVie came in at $4.23B, edged down 1.2% below 2024.
AbbVie Net Income 2024: $4.28B
AbbVie posted net income of $4.28B in 2024, declined 12.0% below 2023.
AbbVie Net Income 2023: $4.86B
In 2023, AbbVie reported net income of $4.86B, plunged 58.9% below 2022.
AbbVie Net Income 2022: $11.84B
AbbVie net income in 2022 was $11.84B, edged up 2.5% from 2021. This figure represents the highest annual value in the available history.
AbbVie Net Income 2021: $11.54B
AbbVie net income in 2021 was $11.54B.
See more financial history for AbbVie (ABBV).
Sector peers by Net Income
Healthcare peers of AbbVie (ABBV), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $6.74B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation